JCR Pharmaceuticals (JCRRF) Stock Price, News & Analysis

Company Overview

JCR Pharmaceuticals Co., Ltd. (OTCMKTS: JCRRF) is a Japan‐based biopharmaceutical company specializing in the research, development, manufacturing and marketing of plasma‐derived and recombinant protein products. Established in the mid‐20th century and headquartered in Kobe, Japan, JCR has built a reputation in plasma fractionation, producing immunoglobulins, albumin preparations and coagulation factor therapies that address a range of immune‐deficient and bleeding disorders.

In addition to its traditional plasma‐derived portfolio, JCR has expanded into regenerative medicine and cell therapy. The company develops bone regeneration products utilizing bone morphogenetic proteins, along with mesenchymal stem cell therapies aimed at treating inflammatory diseases and cardiac conditions. Through in‐house research and strategic alliances, JCR has advanced candidates such as remestemcel‐L, a mesenchymal stem cell treatment licensed to global partners for graft-versus-host disease, and is exploring next-generation regenerative approaches for tissue repair.

JCR Pharmaceuticals serves domestic and select international markets through direct sales in Japan and licensing agreements in North America, Europe and Asia. The company operates cGMP-compliant manufacturing facilities and maintains quality control systems accredited by Japanese and international regulatory authorities. By combining plasma fractionation expertise with cutting-edge cell therapy research, JCR aims to address unmet medical needs and support long-term growth in both established and emerging biopharma markets.

Key Stats

• Today's Range: $5.00 to $5.00
• 50-Day Range: $3.78 to $5.00
• 52-Week Range: $3.78 to $5.00
• Volume: 680 shs
• Average Volume: 293 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

JCRRF Stock Analysis - Frequently Asked Questions

How have JCRRF shares performed this year?

JCR Pharmaceuticals' stock was trading at $4.57 at the beginning of the year. Since then, JCRRF shares have increased by 9.4% and is now trading at $5.00.

How do I buy shares of JCR Pharmaceuticals?

Shares of JCRRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/21/2025
• Next Earnings (Estimated): 7/28/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:JCRRF
• CIK: N/A
• Web: www.jcrpharm.co.jp
• Phone: 81 7 9732 8591
• Fax: N/A
• Employees: 934
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A